Verastem Inc (VSTM) has disclosed a new risk, in the Trade Secrets category.
Verastem Inc. faces a significant business risk pertaining to the ownership and inventorship of its patents and intellectual property (IP). Despite entering into agreements that stipulate the assignment of inventions to the company, there is no guarantee these will be adhered to or effectively transfer IP rights to Verastem Inc. Disputes may arise, particularly in collaborative or sponsored research contexts, challenging the company’s IP claims. Such legal battles could incur considerable costs and, in an adverse outcome, result in the loss of IP rights critical to Verastem Inc.’s operations.
The average VSTM stock price target is $31.67, implying 187.91% upside potential.
To learn more about Verastem Inc’s risk factors, click here.